Immunomedics, Inc.

Immunomedics, Inc. (IMMU) related to its sale to Gilead Sciences, Inc. Under the terms of the agreement, Immunomedics shareholders will receive $88.00 per share for each share of Immunomedics stock owned.

To receive more information regarding the investigation of Immunomedics, Inc. please fill out the form below.